716-75-6 Usage
Uses
Used in Pharmaceutical Industry:
4-(3-FLUORO-4-METHOXYPHENYL)-1,3-THIAZOL-2-AMINE is used as a pharmaceutical candidate for its anti-inflammatory and anti-cancer properties, offering potential therapeutic benefits in the treatment of various diseases and conditions.
Used in Drug Development:
4-(3-FLUORO-4-METHOXYPHENYL)-1,3-THIAZOL-2-AMINE is used as a key component in the development of new drugs, targeting specific cellular pathways to address unmet medical needs and improve patient outcomes.
Used in Research and Development:
4-(3-FLUORO-4-METHOXYPHENYL)-1,3-THIAZOL-2-AMINE is utilized in research and development for exploring its biological activities and potential applications in various therapeutic areas, with the aim of discovering its full range of uses and optimizing its pharmaceutical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 716-75-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,1 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 716-75:
(5*7)+(4*1)+(3*6)+(2*7)+(1*5)=76
76 % 10 = 6
So 716-75-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H9FN2OS/c1-14-9-3-2-6(4-7(9)11)8-5-15-10(12)13-8/h2-5H,1H3,(H2,12,13)
716-75-6Relevant academic research and scientific papers
PYRIMIDINEDIONE-FUSED HETEROCYCLIC COMPOUNDS AS TRPA1 MODULATORS
-
Page/Page column 47, (2010/11/17)
The present invention is related to novel pyrimidinedione-fused heterocyclic compounds as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
QUINAZOLINEDIONE DERIVATIVES AS TRPA1 MODULATORS
-
Page/Page column 17, (2010/01/31)
The present invention provides Quinazolinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by T
